Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Agilent Technologies Broadens Microscopy Portfolio for Life Sciences with Acquisition of TILL Photonics

Abstract:
Agilent Technologies Inc. (NYSE:A) today announced it has completed the acquisition of TILL Photonics GmbH, a developer, manufacturer and marketer of optical, fluorescence microscopy products for life sciences. Financial details were not disclosed.

Agilent Technologies Broadens Microscopy Portfolio for Life Sciences with Acquisition of TILL Photonics

SANTA CLARA, CA | Posted on April 1st, 2008

Agilent announced the agreement to acquire TILL Photonics on March 3, 2008, at Pittcon.

TILL Photonics' innovative, optical microscopes are used in fundamental research, applied science and diagnostics. The acquisition will complement Agilent's atomic force microscope platform and is consistent with Agilent's strategy of providing customers with comprehensive workflow solutions.

Headquartered in Munich, Germany, the company was founded in 1993 by Dr. Rainer Uhl, professor at the BioImaging Center of the University of Munich. TILL Photonics employees have now joined Agilent. More information about TILL Photonics is available at www.till-photonics.com.

TILL Photonics joins the recently formed Materials Science Solutions Unit (MSSU) within Agilent's Life Science and Chemical Analysis business. MSSU's focus is to provide microscopy, spectroscopy and particle analysis solutions for the materials testing, life sciences and chemical analysis markets, as well as to advance nanotechnology.

Agilent in Life Sciences

Agilent is the global leader in gas chromatography and gas chromatography/mass spectrometry, and liquid chromatography and liquid chromatography/mass spectrometry used to analyze the composition of air, water, food, drugs, industrial process streams and forensic evidence. The company is also a leading developer of hardware and software tools for life science analysis including genomics, proteomics and metabolomics. The company pioneered ink-jet in situ synthesis of nucleic acid microarray probes and microfluidic lab-on-a-chip Bioanalyzer and nano LC/MS applications that accelerate customer workflows.

####

About Agilent Technologies Inc.
Agilent Technologies Inc. (NYSE:A) is the world’s premier measurement company and a technology leader in communications, electronics, life sciences and chemical analysis. The company’s 19,000 employees serve customers in more than 110 countries. Agilent had net revenue of $5.4 billion in fiscal 2007. Information about Agilent is available on the Web at www.agilent.com.

NOTE TO EDITORS: Further technology, corporate citizenship and executive news is available on the Agilent news site at www.agilent.com/go/news.

For more information, please click here

Contacts:
Agilent Technologies Inc.
Michele Drake, +1-408-345-8396 (Agilent Corporate)

Eric Endicott, +1-858-373-6385 (Agilent LSCA)

Rodney Gonsalves, +1-408-345-8948 (Investors)

Copyright © Business Wire 2008

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Imaging

New material to make next generation of electronics faster and more efficient With the increase of new technology and artificial intelligence, the demand for efficient and powerful semiconductors continues to grow November 8th, 2024

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Tools

New material to make next generation of electronics faster and more efficient With the increase of new technology and artificial intelligence, the demand for efficient and powerful semiconductors continues to grow November 8th, 2024

Turning up the signal November 8th, 2024

Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024

Faster than one pixel at a time – new imaging method for neutral atomic beam microscopes developed by Swansea researchers August 16th, 2024

Acquisitions/Mergers/Splits

The concept of creating «brain-on-chip» revealed: A team of scientists is working to create brain-like memristive systems providing the highest degree of adaptability for implementing compact and efficient neural interfaces, new-generation robotics, artificial intelligence, perso May 29th, 2020

180 Degree Capital Corp. Life Science Portfolio Company Enters Into Definitive Agreement to be Acquired May 6th, 2020

180 Degree Capital Corp.’s Portfolio Company, Synacor, Inc., Agrees to Merge with Qumu Corporation in All-Stock Transaction February 11th, 2020

Combination of Nanometrics and Rudolph Technologies to Create Onto Innovation October 16th, 2019

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project